Salesforce's most recent trend suggests a bullish bias. One trading opportunity on Salesforce is a Bull Put Spread using a strike $55.00 short put and a strike $50.00 long put offers a potential 24.69% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $55.00 by expiration. The full premium credit of $0.99 would be kept by the premium seller. The risk of $4.01 would be incurred if the stock dropped below the $50.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Salesforce is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Salesforce is bullish.
The RSI indicator is at 34.31 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Salesforce
Amazon Customers Confirm: Cloud Transition Still Biggest Trend
Tue, 16 Feb 2016 20:58:13 GMT
Chowdhry: Salesforce Revenue Acceleration ‘Challenging,' But Positives Balance With Negatives
Tue, 16 Feb 2016 18:34:41 GMT
Benzinga – salesforce.com, inc. (NYSE: CRM ) shares are nearly flat on Tuesday following a one-month stretch that saw its stock fall from the $70s to below $60. Is there more pain in store? Global Equities Research …
Why this analyst believes valuations for enterprise tech names are more attractive than ever
Tue, 16 Feb 2016 17:15:00 GMT
Why salesforce.com, inc. Stock Fell 13% in January
Tue, 16 Feb 2016 12:27:00 GMT
Motley Fool – The customer relationship management software provider skidded along with fellow cloud software providers last month. Can salesforce withstand the souring regard investors seem to hold for this group of …
Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More
Sun, 14 Feb 2016 19:09:35 GMT
Also on Market Tamer…
Follow Us on Facebook